Filter
7088
Filtered Results: 7088
Text search:
medicines
management
Featured
Recommendations
717
New Publications
1836
Language
Document type
No document type
3824
Studies & Reports
1214
Guidelines
1073
Manuals
397
Strategic & Response Plan
259
Training Material
117
Fact sheets
106
Situation Updates
58
Resource Platforms
14
Online Courses
9
Brochures
7
Infographics
7
App
2
Videos
1
Countries / Regions
India
322
Global
268
Kenya
195
South Africa
169
Ethiopia
143
Nepal
132
Sierra Leone
132
Uganda
132
Western and Central Europe
130
Nigeria
127
Liberia
122
Latin America and the Carribbean
114
Africa
104
Tanzania
102
Bangladesh
101
Malawi
99
Zambia
92
Myanmar / Burma
91
Ghana
83
Rwanda
83
Ukraine
79
Syria
78
Congo, Democratic Republic of
67
Eastern Europe
61
Philippines
59
Brazil
53
Namibia
53
Mozambique
52
South–East Asia Region
47
Zimbabwe
42
Indonesia
42
Guinea
40
Russia
39
Asia
35
Lesotho
34
Senegal
33
South Sudan
33
Burkina Faso
31
Germany
31
Colombia
30
Haiti
30
West and Central Africa
30
Cambodia
29
East and Southern Africa
26
Botswana
25
Venezuela
24
Middle East and North Africa
24
Yemen
24
Cameroon
23
Eswatini/ Swaziland
20
Chile
18
Eastern Europe and Central Asia
18
Benin
16
Afghanistan
16
USA
16
Madagascar
15
Pakistan
15
Ecuador
14
Thailand
13
Sudan
13
Peru
12
Western Pacific Region
12
Lebanon
12
Moldova
12
Tajikistan
11
Paraguay
11
Bolivia
11
Argentina
11
Mali
11
Angola
11
Jordan
10
North America
10
Vietnam
10
China
9
Spain
9
Iraq
9
Somalia
9
El Salvador
8
Laos
8
Sri Lanka
8
Central African Republic
8
Mexico
7
Turkey
7
Albania
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
North Macedonia
6
Iran
6
Southern Africa
6
Palestine
6
Libya
6
Guinea-Bissau
5
United Kingdom
5
Portugal
5
Kazakhstan
4
Kyrgyzstan
4
Niger
4
Burundi
4
France
4
Papua New Guinea
4
Egypt
4
Poland
4
Chad
4
Bhutan
4
Timor Leste/ East Timor
3
Gambia
3
Togo
3
Canada
3
Fiji
3
Estonia
3
Uzbekistan
3
Armenia
3
Hungary
3
Saudi Arabia
3
Jamaica
3
Mauritius
3
Romania
3
Serbia
2
Qatar
2
Bulgaria
2
Italy
2
Lithuania
2
Turkmenistan
2
Japan
2
Belarus
2
Nicaragua
2
Greece
2
Honduras
2
Australia
1
Singapore
1
Congo-Brazzaville
1
Morocco
1
Mauritania
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Djibouti
1
Slovakia
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2679
Clinical Guidelines
650
Public Health
430
Key Resources
325
Women & Child Health
321
Capacity Building
136
Pharmacy & Technologies
82
Annual Report MEDBOX
3
Toolboxes
COVID-19
582
Mental Health
561
HIV
485
TB
447
AMR
297
NTDs
244
Caregiver
238
Pharmacy
215
Ebola & Marburg
194
NCDs
191
Rapid Response
190
Planetary Health
189
Disability
186
Conflict
173
Global Health Education
103
Refugee
88
Natural Hazards
78
Health Financing Toolbox
67
Specific Hazards
43
Zika
37
Cholera
30
Social Ethics
24
Polio
18
Malaria
11
Typhoon
1
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Overview
Learning objectives
• Name the general principles of essential care and practice.
• Name management principles of priority MNS conditions.
• Use effective communication skills in interactions with people with MNS conditions.
• Perform assessments for priority MNS conditions.
...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Action Plan for Implementation of Recommendations from the Evaluation of PAHO's Response to COVID-19
An external team evaluated PAHO’s response to COVID-19 to provide an independent assessment of the Pan American Sanitary Bureau’s (PASB) performance regarding preparedness for and response to the COVID-19 pandemic. The evaluations’ final report culminates with eight recommendations for actions...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
For 50 SAM children with medical complications and for a paediatric ward of 10-15 beds for 3 months
The PED/SAM kit is especially designed to provide medicines, renewables and equipment suitable for children and to treat the common childhood illness including severe acute malnutrition with medica...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
